ATE135572T1 - Verwendung von 1,2,4-trioxanen als anti- parasitika und anthelmintika - Google Patents

Verwendung von 1,2,4-trioxanen als anti- parasitika und anthelmintika

Info

Publication number
ATE135572T1
ATE135572T1 AT89303797T AT89303797T ATE135572T1 AT E135572 T1 ATE135572 T1 AT E135572T1 AT 89303797 T AT89303797 T AT 89303797T AT 89303797 T AT89303797 T AT 89303797T AT E135572 T1 ATE135572 T1 AT E135572T1
Authority
AT
Austria
Prior art keywords
trioxanes
activity
antiparasitics
anthelmintics
apart
Prior art date
Application number
AT89303797T
Other languages
English (en)
Inventor
Charles W Univ De Gene Jefford
Ernest-Ansermet Quai
Original Assignee
Oxaco Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxaco Sa filed Critical Oxaco Sa
Application granted granted Critical
Publication of ATE135572T1 publication Critical patent/ATE135572T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT89303797T 1988-04-20 1989-04-17 Verwendung von 1,2,4-trioxanen als anti- parasitika und anthelmintika ATE135572T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888809367A GB8809367D0 (en) 1988-04-20 1988-04-20 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE135572T1 true ATE135572T1 (de) 1996-04-15

Family

ID=10635543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89303797T ATE135572T1 (de) 1988-04-20 1989-04-17 Verwendung von 1,2,4-trioxanen als anti- parasitika und anthelmintika

Country Status (8)

Country Link
EP (1) EP0338756B1 (de)
JP (1) JP2851301B2 (de)
AT (1) ATE135572T1 (de)
CA (1) CA1327317C (de)
DE (1) DE68925990T2 (de)
ES (1) ES2085277T3 (de)
GB (1) GB8809367D0 (de)
GR (1) GR3019690T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217765D0 (en) * 1992-08-21 1992-10-07 Oxaco Sa Oxygenated heterocyclic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672734A5 (de) * 1987-04-03 1989-12-29 Charles W Jefford

Also Published As

Publication number Publication date
DE68925990T2 (de) 1996-10-02
JP2851301B2 (ja) 1999-01-27
EP0338756A3 (en) 1990-11-14
DE68925990D1 (de) 1996-04-25
EP0338756A2 (de) 1989-10-25
GR3019690T3 (en) 1996-07-31
CA1327317C (en) 1994-03-01
JPH0242018A (ja) 1990-02-13
GB8809367D0 (en) 1988-05-25
EP0338756B1 (de) 1996-03-20
ES2085277T3 (es) 1996-06-01

Similar Documents

Publication Publication Date Title
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
DK0556310T3 (da) Quinazolinderivater til forhøjelse af antitumoraktivitet
DE69013913D1 (de) Herstellung von cyanidhaltigen perfluorpolymeren mit iodatomen als vernetzungsstellen.
DE69020796D1 (de) Direkt-Elektroplattieren von Durchgangslöchern.
DE69702705D1 (de) Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren
DE3875159D1 (de) Piperidylaminotriazin-derivate und ihre anwendung als stabilisatoren.
DE3888466D1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
FI853220A7 (fi) Aminoalkoksibentsopyranonit antipsykoottisina ja anksiolyyttisinä aineina.
DK311288D0 (da) Anti-inflammatoriske furanoner
DE59000889D1 (de) Verwendung von nicht hydrolysierten n-vinylformamid-einheiten enthaltenden copolymerisaten als flockungs- und entwaesserungsmittel.
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE3761138D1 (de) Nitratderivate und ihre verwendung als gefaesserweiterer.
DE68910676D1 (de) Verwendung von Creosot als antispastischer Wirkstoff.
DE3584652D1 (de) 2,2,6,6-tetramethyl-4-piperidinyl-derivate und ihre verwendung als lichtstabilisatoren.
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
DE68925990D1 (de) Verwendung von 1,2,4-Trioxanen als Anti-Parasitika und Anthelmintika
DE3676632D1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
SE8502865D0 (sv) Naphtoxazine, ihre herstellung und verwendung
DE3585642D1 (de) Kondensierte benzo-laktame welche als antihypertensive mittel dienen und als antagonisten von cholecystokinin.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
EP0674657A4 (de) Gp41 mütanten und ihre verwendung als hiv therapeutika.
DE59006098D1 (de) Abietinsäurederivate und ihre Verwendung als Elmulgatoren.
DE3863093D1 (de) Sulfosuccinamidsaeuren von polyoxypropylendiaminen und ihre verwendung als emulgatoren.
MX9204642A (es) 1,4-dihidropiridinas con actividad paf-antagonista